Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 5% year on year ...

The proteomics market is experiencing strong growth as demand rises for advanced tools that analyze protein structure, ...

For instance, some products that are used to perform various in vitro diagnostic tests using various technologies involve real time PCR detection systems, immunoassay systems, and others. In vitro ...

Twist Bioscience Corporation Q1 2026 revenue rose 17% and guidance increased. Click for this updated look at TWST stock ...

While the top- and bottom-line numbers for Illumina (ILMN) give a sense of how the business performed in the quarter ended ...

According to Mordor Intelligence, the proteomics market size was valued at USD 29.92 billion in 2025 and projected to grow from USD 33.47 billion in 2026 to reach USD 58.66 billion by 2031, at a CAGR ...

Synthetic Oligonucleotides are set for rapid expansion in healthcare, food production, and data storage. The technology, vital in both existing and new markets, promises vast growth potential often ...

By Vijay Kumar Malesu Why mismatched resistance thresholds between CLSI and EUCAST could be masking the true scale of ...

According to Mordor Intelligence, the proteomics market size was valued at USD 29.92 billion in 2025 and projected to grow from USD 33.47 billion ...

Mir195 enables Ebf1-deficient hematopoietic progenitor cells to mature into B cells, suggesting some miRNA can substitute for transcription factors in differentiation.

Scientists at the University of Virginia School of Medicine are chasing a new way to slow glioblastoma, the deadliest brain ...